Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A multicenter, retrospective study evaluating efficacy and tolerability of perampanel in epilepsy patients in clinical setting.

Trial Profile

A multicenter, retrospective study evaluating efficacy and tolerability of perampanel in epilepsy patients in clinical setting.

Completed
Phase of Trial: Phase IV

Latest Information Update: 04 Dec 2018

At a glance

  • Drugs Perampanel (Primary) ; Lamotrigine; Levetiracetam; Valproate
  • Indications Seizures
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 04 Dec 2018 Results presented at the 72nd Annual Meeting of the American Epilepsy Society
    • 04 Dec 2018 Results presented in an Eisai Inc media release.
    • 04 Dec 2018 According to an Eisai Inc media release, post-hoc analysis from this study were presented at the American Epilepsy Society Annual Meeting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top